Aug 2019

NEW RESEARCH: PATIENTS STILL FACING HURDLES WHEN ACCESSING MEDICINAL CANNABIS

The latest national survey from Chronic Pain Australia found that more than a third of respondents said, after discussing medicinal cannabis as a pain treatment with their GP that they faced difficulty when it came around to the approval process. Read the article here.

ANTG appoints new Business Operations Manager   Australian Natural Therapeutics […]

READ MORE >

ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…

READ MORE >

ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >